Inventor

KULAGOWSKI JANUSZ JOZEF

GB51 patents

⚠️ This page may combine multiple inventors who share the name “KULAGOWSKI JANUSZ JOZEF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

KULAGOWSKI JANUSZ JOZEF

MERCK SHARP & DOHME

Spiro-azacyclic derivatives and their use as therapeutic agents

Benzimidazole derivatives

Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety

Use of NK-1 receptor antagonists for treating bipolar disorders

Use of NK-1 receptor antagonists for treating bipolar disorders

Antipsychotic benzimidazole derivatives

Antipsychotic indazole derivatives

Pyrrolo-pyridine derivatives

Pyrrolo-pyridine derivatives

Spiro-azacyclic derivatives and their use as therapeutic agents

Piperidines and related compounds for treatment of alzheimer&#39;s disease

Spiro-piperidine derivatives and their use as therapeutic agents

Spirocyclic ketones and their use as tachykinin antagonists

Use of NK-1 receptor antagonists for treating cognitive disorders

Spiro-piperidine derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating movement disorders

Furopyridine derivatives

Use of NK-1 receptors antagonists for treating schizophrenic disorders

Tetrahydropyridine derivatives as dopamine receptor subtype ligands

Indole derivatives as dopamine D4 antagonists

Indazole derivatives

Benzofuran derivatives as D4 receptor antagonists

Use of NK-1 receptor antagonists for treating stress disorders

Use of NK-1 receptor antogonists for treating substance use disorders

Octahydronaphthyridine derivatives

Pentaaza-cyclopental[a]naphthalene derivatives as ligands for GABAa α5 receptors

Azabicyclic ether derivatives and their use as therapeutic agents

Sulfone derivatives as 5-HT7 receptor ligands

Azabicyclic amine derivatives and their use as therapeutic agents

Use of NK-1 receptor antagonists for treating amnestic disorders

Use of NK-1 receptor antagonists for treating major depressive disorders

Tetrahydropyridine derivatives as dopamine receptor subtype ligands

Indole derivatives as dopamine D4 antagonists

Methanesulfonate salts of antipsychotic benzofuran derivatives

5-HT7 receptor antagonists

Azabicyclic spiroether derivatives and their use as therapeutic agents

JANSSEN PHARMACEUTICA NV

Substituted azaindoline derivatives as NIK inhibitors

Cyanoindoline derivatives as NIK inhibitors

Substituted cyanoindoline derivatives as NIK inhibitors

Heteroaromatic derivatives as NIK inhibitors

6-membered heteroaromatic substituted cyanoindoline derivatives as NIK inhibitors

1-(4-pyrimidinyl)-1H-pyrrolo[3,2-c]pyridine derivatives as NIK inhibitors

Compounds as NIK inhibitors

3-(1H-pyrazol-4-yl)-1H-pyrrolo[2,3-c]pyridine derivatives as NIK inhibitors

Pyrazole derivatives as NIK inhibitors

MERCK SHARP

Use of NK-1 receptor antagonists for treating sexual dysfunctions

BLENCH TOBY JONATHAN

Compounds

MERCH SHARP & DOHME LTD

Tetrahydropyridinylmethyl derivatives of pyrrolo 2,3-B!pyridine

CHIESI FARMA SPA

Compounds

HOFFMANN LA ROCHE

Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase

Piperidines and related compounds for treatment of alzheimer's disease